NEW YORK, Oct. 28 - Biotique Systems today said that Merck has licensed its BLIS platform.
BLIS, which stands for Biotique local integration system, helps researchers integrate, analyze, and visualize biotech data, according to Biotique.
Already have a GenomeWeb or 360Dx account?Login Now.
360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.
The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.
In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.
Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.